Filing Details
- Accession Number:
- 0000945769-10-000004
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-01-07 12:00:00
- Reporting Period:
- 2010-01-05
- Filing Date:
- 2010-01-07
- Accepted Time:
- 2010-01-07 16:01:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887497 | Hi Tech Pharmacal Co Inc | HITK | Pharmaceutical Preparations (2834) | 112638720 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263136 | J William Peters | C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701 | Vp And Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-01-05 | 2,517 | $19.95 | 2,517 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-01-05 | 2,517 | $29.02 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-01-05 | 2,517 | $0.00 | 2,517 | $19.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,983 | 2004-09-08 | 2013-09-08 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.25, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) of this Form 4.
- Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- The option became exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- Other than the options to acquire an aggregate of 4,983 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 100,000 shares of the Company's stock (for total options to acquire an aggegate of 104,983 shares held by the filer). The additional options were granted on various dates, with varying exercise prices and exercisable and expiration dates.